Skip to main content
Premium Trial:

Request an Annual Quote

Competition Time

Researchers looking for alternative support for their projects amid a tight funding environment might want to consider two industry-funded award competitions launched this week.

One, called the Populus Award, is sponsored by UK-based Population Genetics and will provide "financial and expert practical support for the completion of a multi-sample gene sequencing project" using the company's proprietary molecular tagging technology.

The company is soliciting abstracts from researchers "undertaking a range of population genetics studies." Applications can submitted here until Nov. 30. The winning team will be announced in January 2013.

In another competition, Assay Depot, the Rare Genomics Institute, and 19 life science companies are partnering on a rare disease research challenge called Be HEARD, or Helping Empower and Accelerate Research Discoveries.

The sponsoring organizations are donating $400,000 worth of technology, services, and resources as well as a $10,000 cash prize.

Non-profits, academic researchers, rare disease advocacy groups, families of rare disease patients, and for-profit companies are eligible to submit proposals here before Dec. 15.

Industry sponsors include Biopta, Charles River Laboratories, DNA Software, HistoRx, Ingenuity Systems, and Taconic.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.